Cargando…
Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
The treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC) is a highly unmet medical need. The classic treatment approach for these patients—androgen deprivation therapy (ADT) alone—until metastatic progression is now considered suboptimal. Several randomized phase III clinical tr...
Autores principales: | López-Campos, Fernando, Conde-Moreno, Antonio, Barrado Los Arcos, Marta, Gómez-Caamaño, Antonio, García-Gómez, Raquel, Hervás Morón, Asunción |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619952/ https://www.ncbi.nlm.nih.gov/pubmed/34834544 http://dx.doi.org/10.3390/jpm11111190 |
Ejemplares similares
-
Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014) -
Node Oligorecurrence in Prostate Cancer: A Challenge
por: Zapatero, Almudena, et al.
Publicado: (2023) -
Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019) -
Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
por: Henriquez, Ivan, et al.
Publicado: (2021) -
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2022)